![Pharmaceutics | Free Full-Text | Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy Pharmaceutics | Free Full-Text | Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-14-01768/article_deploy/html/images/pharmaceutics-14-01768-g001.png?1661501042)
Pharmaceutics | Free Full-Text | Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy
![The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology](https://journals.asm.org/cms/10.1128/MCB.00085-21/asset/dff043f5-c94a-44b4-b256-a6fc94aa8264/assets/images/large/mcb.00085-21-f004.jpg)
The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology
![The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology](https://journals.asm.org/cms/10.1128/MCB.00085-21/asset/dc4211d1-9eba-4cf7-a636-73c965767ee1/assets/images/large/mcb.00085-21-f005.jpg)
The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology
![The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway | Molecular and Cellular Biology](https://journals.asm.org/cms/asset/986028bf-ed30-4689-b34c-1d9265c5e7da/mcb.2021.41.issue-9.cover.gif)